Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.82 USD | +6.11% | +16.82% | +124.71% |
Financials (USD)
Sales 2024 * | 148M | Sales 2025 * | 178M | Capitalization | 542M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | 1M | EV / Sales 2024 * | 3.67 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.05 x |
P/E ratio 2024 * |
-40
x | P/E ratio 2025 * |
540
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.31% |
Latest transcript on Heron Therapeutics, Inc.
1 day | +6.25% | ||
1 week | +16.82% | ||
Current month | +3.24% | ||
1 month | +34.51% | ||
3 months | +49.22% | ||
6 months | +163.45% | ||
Current year | +124.71% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 23-06-15 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 23-02-20 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 21-09-19 |
Craig Johnson
BRD | Director/Board Member | 62 | 14-01-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 3.825 | +6.25% | 867 707 |
24-06-04 | 3.6 | -6.74% | 2,127,791 |
24-06-03 | 3.86 | +4.32% | 2,839,346 |
24-05-31 | 3.7 | +7.25% | 2,664,356 |
24-05-30 | 3.45 | +5.50% | 2,537,128 |
Delayed Quote Nasdaq, June 05, 2024 at 01:27 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+124.71% | 542M | |
+54.04% | 55.7B | |
+41.08% | 39.91B | |
-5.60% | 39.57B | |
-5.56% | 28.16B | |
+16.32% | 26.3B | |
-20.36% | 18.94B | |
+32.98% | 12.17B | |
+26.74% | 12.12B | |
+2.38% | 12.12B |
- Stock Market
- Equities
- HRTX Stock